The heat on healthcare’s middlemen — pharmacy benefit managers (PBM) — is increasing, but a tangible solution may still be far off. Lawmakers grilled PBM executives Tuesday at the third hearing in a ...

The Consolidated Appropriations Act of 2026 acts as a first step in addressing prescription drug pricing challenges related to the role of pharmacy benefit managers (PBMs).

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy ...

The agency voted 4-1 to issue the report on pharmacy benefit managers, with Republican Commissioner Melissa Holyoak being the sole dissenter. The six largest pharmacy benefit managers control 94% of ...

The Consolidated Appropriations Act of 2026 and the Department of Labor’s proposed rule implement major PBM reforms for employers, but don’t include everything they want, including a ban on spread ...

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen. The ...